200,000+ products from a single source!

sales@angenechem.com

Home > Bromides > 101-26-8

101-26-8

101-26-8 | 3-(Dimethylcarbamoyloxy)-1-Methylpyridinium Bromide

CAS No: 101-26-8 Catalog No: AG0033GW MDL No:MFCD00079283

Product Description

Catalog Number:
AG0033GW
Chemical Name:
3-(Dimethylcarbamoyloxy)-1-Methylpyridinium Bromide
CAS Number:
101-26-8
Molecular Formula:
C9H13BrN2O2
Molecular Weight:
261.1157
MDL Number:
MFCD00079283
IUPAC Name:
(1-methylpyridin-1-ium-3-yl) N,N-dimethylcarbamate;bromide
InChI:
InChI=1S/C9H13N2O2.BrH/c1-10(2)9(12)13-8-5-4-6-11(3)7-8;/h4-7H,1-3H3;1H/q+1;/p-1
InChI Key:
VNYBTNPBYXSMOO-UHFFFAOYSA-M
SMILES:
C[n+]1cccc(c1)OC(=O)N(C)C.[Br-]
EC Number:
202-929-9
UNII:
KVI301NA53

Properties

Complexity:
183  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
260.016g/mol
Formal Charge:
0
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
261.119g/mol
Monoisotopic Mass:
260.016g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
33.4A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0

Literature

Title Journal
Increased butyrate priming in the gut stalls microbiome associated-gastrointestinal inflammation and hepatic metabolic reprogramming in a mouse model of Gulf War Illness. Toxicology and applied pharmacology 20180701
Zebrafish is a predictive model for identifying compounds that protect against brain toxicity in severe acute organophosphorus intoxication. Archives of toxicology 20170101
Chronic Oxidative Stress, Mitochondrial Dysfunction, Nrf2 Activation and Inflammation in the Hippocampus Accompany Heightened Systemic Inflammation and Oxidative Stress in an Animal Model of Gulf War Illness. Frontiers in molecular neuroscience 20170101
Exposure to Gulf War Illness chemicals induces functional muscarinic receptor maladaptations in muscle nociceptors. Neurotoxicology 20160501
Gulf War agent exposure causes impairment of long-term memory formation and neuropathological changes in a mouse model of Gulf War Illness. PloS one 20150101
Persistent modification of Nav1.9 following chronic exposure to insecticides and pyridostigmine bromide. Toxicology and applied pharmacology 20140615
Myotubular myopathy and the neuromuscular junction: a novel therapeutic approach from mouse models. Disease models & mechanisms 20121101
Autonomic nervous system modulation affects the inflammatory immune response in mice with acute Chagas disease. Experimental physiology 20121101
Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature. Multiple sclerosis (Houndmills, Basingstoke, England) 20120801
Myasthenia gravis and endurance exercise. American journal of physical medicine & rehabilitation 20120801
Gulf War illnesses are autoimmune illnesses caused by reactive oxygen species which were caused by nerve agent prophylaxis. Medical hypotheses 20120801
A prospective, 1-year follow-up study of postural tachycardia syndrome. Mayo Clinic proceedings 20120801
Neuregulin-1 is neuroprotective in a rat model of organophosphate-induced delayed neuronal injury. Toxicology and applied pharmacology 20120715
Prolonged release matrix tablet of pyridostigmine bromide: formulation and optimization using statistical methods. Pakistan journal of pharmaceutical sciences 20120701
Effects of anticholinesterase drugs on biomarkers and behavior of pumpkinseed, Lepomis gibbosus (Linnaeus, 1758). Journal of environmental monitoring : JEM 20120501
[Preparation and quality control of pyridostigmine bromide orally disintegrating tablet]. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20120501
A 90 year old man with difficulty swallowing and proximal muscle weakness. BMJ (Clinical research ed.) 20120404
A comparison of the efficacy of newly developed reversible inhibitors of acetylcholinesterase with commonly used pyridostigmine as pharmacological pre-treatment of soman-poisoned mice. Basic & clinical pharmacology & toxicology 20120401
Myasthenia gravis: a real emergency. International emergency nursing 20120401
Preparation and characterization of poly(lactic acid) nanoparticles for sustained release of pyridostigmine bromide. Die Pharmazie 20120401
A retrospective clinical study of the treatment of slow-channel congenital myasthenic syndrome. Journal of neurology 20120301
Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature. Leukemia & lymphoma 20120301
Seronegative myasthenia gravis with bladder dysfunction. Revue neurologique 20120301
Role of a novel pyridostigmine bromide-phospholipid nanocomplex in improving oral bioavailability. Archives of pharmacal research 20120301
Vincristine induced cranial neuropathy. The Journal of the Association of Physicians of India 20120301
Investigation of anticholinergic and non-steroidal anti-inflammatory prodrugs which reduce chemically induced skin inflammation. Journal of applied toxicology : JAT 20120201
Gulf War syndrome as a part of the autoimmune (autoinflammatory) syndrome induced by adjuvant (ASIA). Lupus 20120201
Myasthenia gravis in Jamaican children: a 12-year institutional review. Paediatrics and international child health 20120201
Complex factors in the etiology of Gulf War illness: wartime exposures and risk factors in veteran subgroups. Environmental health perspectives 20120101
Delayed reduction of hippocampal synaptic transmission and spines following exposure to repeated subclinical doses of organophosphorus pesticide in adult mice. Toxicological sciences : an official journal of the Society of Toxicology 20120101
Pyridostigmine bromide protection against acetylcholinesterase inhibition by pesticides. Journal of biochemical and molecular toxicology 20120101
Anesthesia and myasthenia gravis. Acta anaesthesiologica Scandinavica 20120101
[+]-Huperzine A protects against soman toxicity in guinea pigs. Neurochemical research 20111201
Proteomic CNS profile of delayed cognitive impairment in mice exposed to Gulf War agents. Neuromolecular medicine 20111201
Discordant thymectomy in identical twins concordant for myasthenia gravis. Annals of internal medicine 20111004
Diagnosis of congenital myasthenic syndrome with mutation of the RAPSN gene after general anaesthesia. European journal of anaesthesiology 20111001
HIV-associated myasthenia gravis and impacts of HAART: one case report and a brief review. Clinical neurology and neurosurgery 20111001
Treatment of myasthenia gravis: focus on pyridostigmine. Clinical drug investigation 20111001
Organophosphates dysregulate dopamine signaling, glutamatergic neurotransmission, and induce neuronal injury markers in striatum. Journal of neurochemistry 20111001
[Bioequivalence of pyridostigmine bromide dispersible tablets in rabbits]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20111001
In vitro kinetic interactions of pyridostigmine, physostigmine and soman with erythrocyte and muscle acetylcholinesterase from different species. Toxicology letters 20110925
Clinical profiles of Thai patients with ocular myasthenia gravis in Siriraj Hospital. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20110901
Chemical interactions and Gulf War illnesses. Chemico-biological interactions 20110815
Retention study of some cation-type compounds using bile acid sodium salts as ion pairing agents in liquid chromatography. Biomedical chromatography : BMC 20110801
Candida esophagitis as the cause of swallowing disturbances in an 85-year-old patient with myasthenia gravis. Zeitschrift fur Gerontologie und Geriatrie 20110801
Childhood myasthenia gravis: clinical features and outcomes. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20110801
Myasthenia gravis in a one year eight months old female child. Journal of the Indian Medical Association 20110801
Autoimmune autonomic ganglionopathy after a CNS infection. Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20110601
Pyridostigmine in the treatment of postural orthostatic tachycardia: a single-center experience. Pacing and clinical electrophysiology : PACE 20110601
Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies. Neuromuscular disorders : NMD 20110601
Myasthenia gravis as a cause of head drop in Parkinson disease. The neurologist 20110501
In vitro kinetic interactions of DEET, pyridostigmine and organophosphorus pesticides with human cholinesterases. Chemico-biological interactions 20110425
Delayed presentation of invasive thymoma in myasthenia gravis: a case report. Neuromuscular disorders : NMD 20110401
Protection of human muscle acetylcholinesterase from soman by pyridostigmine bromide. Muscle & nerve 20110401
Congenital myasthenic syndrome due to homozygous CHRNE mutations: report of patients in Arabia. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 20110301
Treatment for Lambert-Eaton myasthenic syndrome. The Cochrane database of systematic reviews 20110216
Antiarrhythmogenic effects of a neurotoxin from the spider Phoneutria nigriventer. Toxicon : official journal of the International Society on Toxinology 20110201
[Postural orthostatic tachycardia syndrome: current concepts in pathophysiology, diagnosis and therapeutic options]. Fortschritte der Neurologie-Psychiatrie 20110201
A Cys-loop mutation in the Caenorhabditis elegans nicotinic receptor subunit UNC-63 impairs but does not abolish channel function. The Journal of biological chemistry 20110128
Congenital myasthenic syndrome: a case report. Genetic counseling (Geneva, Switzerland) 20110101
Myasthenia gravis requiring pyridostigmine treatment in a national population cohort. European journal of neurology 20101201
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals 20101201
Technical report: exploring the basis of congenital myasthenic syndromes in an undergraduate course, using the model organism, Caenorhabditis elegans. Invertebrate neuroscience : IN 20101101
Benefits from sustained-release pyridostigmine bromide in myasthenia gravis: results of a prospective multicenter open-label trial. Clinical neurology and neurosurgery 20101101
Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure. Hypertension (Dallas, Tex. : 1979) 20101101
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Perspectives on the use of scopolamine as an adjunct treatment to enhance survival following organophosphorus nerve agent poisoning. Military medicine 20101101
Visual and systemic outcomes in pediatric ocular myasthenia gravis. American journal of ophthalmology 20101001
Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposure. Chemico-biological interactions 20100906
Cholinesterase inhibitors and stress: effects on brain muscarinic receptor density in mice. Neurotoxicology 20100901
Diagnostic challenge: Myasthenia gravis in the emergency department. Journal of the American Academy of Nurse Practitioners 20100901
[Course and treatment of myasthenia gravis during pregnancy]. Der Nervenarzt 20100801
[Bizerine: new anticholinesterase drug with selective gastrointestinal action]. Eksperimental'naia i klinicheskaia farmakologiia 20100801
Pyridostigmine-induced dystonic blepharospasm in a patient with ocular myasthenia gravis. Movement disorders : official journal of the Movement Disorder Society 20100715
Gabapentin-induced exacerbation of myasthenia gravis. Muscle & nerve 20100701
Long-acting anticholinesterases for myasthenia gravis: synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine. Bioorganic & medicinal chemistry 20100701
The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20100601
Use of pyridoxine and pyridostigmine in children with vincristine-induced neuropathy. Indian journal of pediatrics 20100601
[Dysphagia as the sole manifestation of myasthenia gravis]. Acta gastroenterologica Latinoamericana 20100601
Mycophenolate mofetil treatment in dogs with serologically diagnosed acquired myasthenia gravis: 27 cases (1999-2008). Journal of the American Veterinary Medical Association 20100315
Unsatisfactory outcomes in myasthenia gravis: influence by care providers. Journal of neurology 20100301
Rituximab in the management of refractory myasthenia gravis. Muscle & nerve 20100301
Continuous administration of pyridostigmine improves immobilization-induced neuromuscular weakness. Critical care medicine 20100301
Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications. Bioorganic & medicinal chemistry letters 20100301
Acute electrophysiologic consequences of pyridostigmine inhibition of cholinesterase in humans. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20100201
Post-polio syndrome: Pathophysiological hypotheses, diagnosis criteria, drug therapy. Annals of physical and rehabilitation medicine 20100201
Prolonged cardioprotective effect of pyridostigmine encapsulated in liposomes. Life sciences 20100102
Treatment with tertiary oximes prevents seizures and improves survival following sarin intoxication. Journal of molecular neuroscience : MN 20100101
Relief from episodic weakness with pyridostigmine in paramyotonia congenita: a family study. Muscle & nerve 20100101
Myasthenia gravis and return to flying status. Aviation, space, and environmental medicine 20100101
Autoimmune myasthenia gravis in a ferret. Journal of the American Veterinary Medical Association 20091215
Refinement of the clinical phenotype in musk-related congenital myasthenic syndromes. Neurology 20091201
Pyridostigmine, working and toxicity on platelet. The Malaysian journal of pathology 20091201
Gulf War illness: Effects of repeated stress and pyridostigmine treatment on blood-brain barrier permeability and cholinesterase activity in rat brain. Behavioural brain research 20091105
Teaching NeuroImages: reversible ectropion in myasthenia gravis. Neurology 20091020
Serum of patients with oral pemphigus vulgaris impairs keratinocyte wound repair in vitro: a time-lapse study on the efficacy of methylprednisolone and pyridostigmine bromide. Oral diseases 20091001
Management of myasthenic conditions: nonimmune issues. Current opinion in neurology 20091001
Retrospective population pharmacokinetic/pharmacodynamic analysis of pyridostigmine, a cholinesterase inhibitor, in Chinese males. The Journal of pharmacy and pharmacology 20090901
Association of preeclampsia and myasthenia: a case report. The Journal of reproductive medicine 20090901
Late onset generalized myasthenia gravis presenting with facial weakness and bulbar signs without extraocular muscle involvement. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20090801
Acetylcholine-esterase inhibitor pyridostigmine decreases T cell overactivation in patients infected by HIV. AIDS research and human retroviruses 20090801
Efficacy of 3,4-diaminopyridine and pyridostigmine in the treatment of Lambert-Eaton myasthenic syndrome: a randomized, double-blind, placebo-controlled, crossover study. Clinical pharmacology and therapeutics 20090701
Congenital myasthenic syndrome with episodic apnea. Pediatric neurology 20090701
Decompensating esophoria as the presenting feature of myasthenia gravis. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 20090601
Vincristine induced unilateral ptosis. Journal of pediatric hematology/oncology 20090601
Effect of pyridostigmine (Mestinon) on human platelet aggregation. The Malaysian journal of pathology 20090601
Allogeneic hematopoietic cell transplantation for refractory myasthenia gravis. Archives of neurology 20090501
Pseudo plus-minus lid syndrome. Archives of neurology 20090501
Graded response to thymectomy in children with myasthenia gravis. Journal of child neurology 20090401
Toxicity and characterization of cholinesterase-inhibition induced by diisopropyl fluorophosphate in Artemia salina larvae. Ecotoxicology and environmental safety 20090301
The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers. Journal of clinical gastroenterology 20090301
Why postprandial abdominal bloating in patients with irritable bowel syndrome does not respond to prokinetics. The American journal of gastroenterology 20090301
Cholinergic stimulation improves autonomic and hemodynamic profile during dynamic exercise in patients with heart failure. Journal of cardiac failure 20090301
Clinical implications of new neuromuscular concepts and agents: so long, neostigmine! So long, sux! Journal of critical care 20090301
Terbutaline in myasthenia gravis: a pilot study. Journal of the neurological sciences 20090215
Repeated stress in combination with pyridostigmine Part I: long-term behavioural consequences. Behavioural brain research 20090211
Accommodation of physostigmine and its analogues by acetylcholinesterase is dominated by hydrophobic interactions. The Biochemical journal 20090101
Membrane electrodes for the determination of pyridostigmine bromide. Journal of AOAC International 20090101
An unusual presentation of myasthenia gravis. West African journal of medicine 20090101
[Myasthenia gravis]. La Revue du praticien 20081231
Justice delayed: acknowledging the reality of Gulf War illness. Lancet (London, England) 20081129
Left ventricular long-axis function in myasthenia gravis. Journal of neurology 20081101
Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors. The American journal of gastroenterology 20081001
Bradycardia, hypotension and bronchospasm following remifentanil-propofol in a myathenic paitent treated by pyridostigmine--a case report. Middle East journal of anaesthesiology 20081001
An unusual primary presentation of myasthenia gravis. The British journal of oral & maxillofacial surgery 20080901
Myasthenia gravis associated with lupus nephritis. Lupus 20080901
[Integrated traditional Chinese and Western medicine in treating 31 cases of myasthenia gravis]. Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine 20080901
Pilot study of pyridostigmine in constipated patients with autonomic neuropathy. Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20080801
Intestinal gas and bloating: effect of prokinetic stimulation. The American journal of gastroenterology 20080801
Long-term outcomes of pediatric ocular myasthenia gravis. Ophthalmology 20080701
Peripheral chemokine receptors, their ligands, cytokines and Alzheimer's disease. Journal of Alzheimer's disease : JAD 20080601
Myasthenia gravis associated with autoimmune thyroid disease: a report of two patients. Annals of African medicine 20080601
Cholinergic stimulation with pyridostigmine prevents the impairment in ventricular function during mental stress in coronary artery disease patients. International journal of cardiology 20080425
Identical kinetics of human erythrocyte and muscle acetylcholinesterase with respect to carbamate pre-treatment, residual activity upon soman challenge and spontaneous reactivation after withdrawal of the inhibitors. Toxicology 20080418
Long-term clinical outcome after extended thymectomy combined postoperative high-dose steroid therapy for juvenile myasthenia gravis. Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 20080401
Electrophysiological signs and the prevalence of adverse effects of acetylcholinesterase inhibitors in patients with myasthenia gravis. Muscle & nerve 20080301
Reversal of rocuronium-induced neuromuscular blockade by pyridostigmine in patients with Duchenne muscular dystrophy. Paediatric anaesthesia 20080301
In vitro metabolism and interactions of pyridostigmine bromide, N,N-diethyl-m-toluamide, and permethrin in human plasma and liver microsomal enzymes. Xenobiotica; the fate of foreign compounds in biological systems 20080301
Treatment of pyridostigmine-induced AV block with hyoscyamine in a patient with myasthenia gravis. Journal of cardiovascular electrophysiology 20080201
Fiberoptic endoscopic evaluation of swallowing with simultaneous Tensilon application in diagnosis and therapy of myasthenia gravis. Journal of neurology 20080201
A six-month randomized controlled trial of exercise and pyridostigmine in the treatment of fibromyalgia. Arthritis and rheumatism 20080201
Myasthenia gravis: an unrecognized cause of head drop in Parkinson's disease. Parkinsonism & related disorders 20080101
Myasthenia gravis crisis. Southern medical journal 20080101
A cause of reversible dysphagia: an unusual presentation of myasthenia gravis. European journal of internal medicine 20080101
[Lambert-Eaton Myasthenic Syndrome associated with vocal cord carcinoma]. Revue neurologique 20080101
Extended transsternal thymectomy for myasthenia gravis: a report of 19 consecutive cases. Acta chirurgica Belgica 20080101
Early onset myasthenia gravis with atypical features. Kathmandu University medical journal (KUMJ) 20080101
[Diagnostics and treatment of myasthenia gravis in children]. Przeglad lekarski 20080101
Protective effect of reversible cholinesterase inhibitors (tacrine, pyridostigmine) and eqbuche against VX poisoning and brain acetylcholinesterase inhibition in rats. Acta medica (Hradec Kralove) 20080101
[Development of a myasthenia crisis during interferon treatment for chronic C hepatitis]. Gastroenterologie clinique et biologique 20071201
[Electroacupuncture warming therapy combined with western medicine for treatment of myasthenia gravis and effect on IL-4 level in the patients]. Zhongguo zhen jiu = Chinese acupuncture & moxibustion 20071201
Treatment of botulinum toxin-induced eyelid ptosis with anticholinesterases. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 20071101
When the patient fails to respond to treatment: myasthenia gravis. Practical neurology 20071101
Formulation design of an HPMC-based sustained release tablet for pyridostigmine bromide as a highly hygroscopic model drug and its in vivo/in vitro dissolution properties. Drug development and industrial pharmacy 20071101
Latency and exposure-health associations in Gulf War veterans with early fatigue onsets: a case-control study. Annals of epidemiology 20071001
Pyridoxine and pyridostigmine treatment in vincristine-induced neuropathy. Pediatric hematology and oncology 20070901
Anti-musk antibody after thymectomy in a previously seropositive myasthenic child. Neurology 20070821
[Successful treatment of a Lambert-Eaton myasthenic syndrome patient with 3,4-diaminopyridine]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20070810
Is cerebral involvement an occasional feature of muscle-specific kinase antibody-positive syndrome? European journal of neurology 20070801
Brugada syndrome in the presence of coronary artery disease and parasympathomimetic drug therapy. Pacing and clinical electrophysiology : PACE 20070801
Myasthenia gravis and Lambert-Eaton myasthenic syndrome in the same patient. Muscle & nerve 20070701
Effect of acetylcholinesterase inhibition with pyridostigmine on cardiac parasympathetic function in sedentary adults and trained athletes. American journal of physiology. Heart and circulatory physiology 20070701
Myasthenia gravis in ectopic thymoma presenting as pleural masses. Lung cancer (Amsterdam, Netherlands) 20070701
Post-varicella myasthenia gravis. Singapore medical journal 20070601
Extrapolating from animal studies to the efficacy in humans of a pretreatment combination against organophosphate poisoning. Archives of toxicology 20070501
A combination of 6 months of treatment with pyridostigmine and triweekly exercise fails to improve insulin-like growth factor-I levels in fibromyalgia, despite improvement in the acute growth hormone response to exercise. The Journal of rheumatology 20070501
[Pyridostigmine in the treatment of primary orthostatic hypotension]. Neurologia (Barcelona, Spain) 20070501
An investigation of acetylcholine released in skeletal muscle and protein unbound drug released in blood based on the pyridostigmine bromide (pretreatment drug) sustained-release pellets by microdialysis technique in the rabbit model. Neuroscience letters 20070418
Effects of combined, multiple stressors on pyridostigmine-induced acute toxicity in rats. Archives of toxicology 20070401
Dropped head as an unusual presenting sign of myasthenia gravis. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20070401
Concurrence of non-myasthenic symptoms with myasthenia gravis. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20070401
Formulation design of a highly hygroscopic drug (pyridostigmine bromide) for its hygroscopic character improvement and investigation of in vitro/in vivo dissolution properties. Drug development and industrial pharmacy 20070401
Mycophenolate mofetil - as an adjunctive immunosuppressive therapy in refractory myasthenia gravis: The Singapore experience. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20070301
Comparison of two pre-exposure treatment regimens in acute organophosphate (paraoxon) poisoning in rats: tiapride vs. pyridostigmine. Toxicology and applied pharmacology 20070301
Is there still a role for edrophonium in diagnosing ocular myasthenia. European journal of neurology 20070301
Factors associated with insensitivity to pyridostigmine therapy in Thai patients with ocular myasthenia gravis. Asian Pacific journal of allergy and immunology 20070301
Myasthenia gravis mimicking unilateral vocal fold paralysis at presentation. The Journal of laryngology and otology 20070201
Pyridostigmine in the treatment of orthostatic intolerance. The Annals of pharmacotherapy 20070201
Mycophenolate mofetil substitution for cyclosporine-dependent myasthenia gravis and nephrotoxicity. Internal medicine journal 20070101
Nerve agents. The neurologist 20070101
Effects of combined exposure to pyridostigmine bromide and shaker stress on acoustic startle response, pre-pulse inhibition and open field behavior in mice. Journal of applied toxicology : JAT 20070101
[Anesthesia with remifentanil for thoracoscopic thymectomy in a girl with myasthenia gravis]. Revista espanola de anestesiologia y reanimacion 20070101
Dropped head sign as the only symptom of myasthenia gravis. Internal medicine (Tokyo, Japan) 20070101
[Criminal clozapine intoxications]. Anesteziologiia i reanimatologiia 20070101
Myasthenia gravis and thymectomy: an anaesthetic approach. Acta anaesthesiologica Belgica 20070101
[Treatment of Lambert-Eaton syndrome with 3,4- diaminopyridine and pyridostigmine]. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20070101
An atypical course of myasthenia gravis. Proceedings of the Western Pharmacology Society 20070101
Development of methods to measure humoral immune responses against selected antigens in the common marmoset (Callithrix jacchus) and the effect of pyridostigmine bromide administration. International immunopharmacology 20061205
Multiple vaccine and pyridostigmine bromide interactions in the common marmoset Callithrix jacchus: immunological and endocrinological effects. International immunopharmacology 20061205
[Myasthenia gravis and intestinal resection: is dehiscence likely to occur?]. Minerva chirurgica 20061201
Therapeutic and neuroprotective efficacy of pharmacological pretreatment and antidotal treatment of acute tabun or soman poisoning with the emphasis on pretreatment drug PANPAL. Arhiv za higijenu rada i toksikologiju 20061201
Effect of pyridostigmine, pralidoxime and their combination on survival and cholinesterase activity in rats exposed to the organophosphate paraoxon. Archives of toxicology 20061101
Cerebral acetylcholine and choline contents and turnover following low-dose acetylcholinesterase inhibitors treatment in rats. Archives of toxicology 20061101
Pharmacokinetics of pyridostigmine in a child with postural tachycardia syndrome. Pediatrics 20061101
Coexistence of pernicious anemia and myasthenia gravis--a rare combination of autoimmune diseases in Taiwan. Journal of the Formosan Medical Association = Taiwan yi zhi 20061101
Autoimmune gastrointestinal dysmotility treated successfully with pyridostigmine. Gastroenterology 20061101
[Bilateral paravertebral block anesthesia for thymectomy by video-assisted thoracoscopy in patients with myasthenia gravis]. Revista espanola de anestesiologia y reanimacion 20061101
Persistence of CD16+/CD56-/2B4+ natural killer cells: a highly dysfunctional NK subset expanded in ocular myasthenia gravis. Journal of neuroimmunology 20061001
Acetylcholinesterase inhibition in patients with orthostatic intolerance. Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society 20061001
Pyridostigmine, diethyltoluamide, permethrin, and stress: a double-blind, randomized, placebo-controlled trial to assess safety. Mayo Clinic proceedings 20061001
Ranitidine in acute high-dose organophosphate exposure in rats: effect of the time-point of administration and comparison with pyridostigmine. Basic & clinical pharmacology & toxicology 20061001
Development of miotic cross-tolerance between pyridostigmine and sarin vapor. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20061001
A rare combination of thymic tumor: radiologically invisible thymolipoma associated with myasthenia gravis. Neurology India 20060901
Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents. Proceedings of the National Academy of Sciences of the United States of America 20060829
Eosinophilia, myositis, and myasthenia gravis associated with a thymoma. Muscle & nerve 20060801
The 'slurp' test: bedside evaluation of bulbar muscle fatigue. Pediatrics 20060801
Pyridostigmine in autonomic failure: can we treat postural hypotension and bladder dysfunction with one drug? Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20060801
Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds. Biochemical pharmacology 20060728
Available treatment options for the management of Lambert-Eaton myasthenic syndrome. Expert opinion on pharmacotherapy 20060701
Neuromyotonia and myasthenia gravis in the absence of thymoma. European journal of neurology 20060701
Cholinergic overstimulation supports conditioned-facilitated startle but not conditioned hyperalgesia. Pharmacology, biochemistry, and behavior 20060701
Multiple vaccine and pyridostigmine interactions: effects on cognition, muscle function and health outcomes in marmosets. Pharmacology, biochemistry, and behavior 20060601
Dysphonia as first symptom of late-onset myasthenia gravis. Journal of general internal medicine 20060601
Vincristine induced cranial polyneuropathy. Indian journal of pediatrics 20060601
Multiple vaccine and pyridostigmine interactions: effects on EEG and sleep in the common marmoset. Pharmacology, biochemistry, and behavior 20060601
[Myasthenia gravis and hyperthyroidism: two cases]. Annales d'endocrinologie 20060601
Residual wires and autonomic failure treatment. Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20060601
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Interaction of pyridostigmine bromide and N,N-diethyl-m-toluamide alone and in combination with P-glycoprotein expressed in Escherichia coli leaky mutant. Journal of toxicology and environmental health. Part A 20060501
Myasthenia gravis accompanied with hypokalemic periodic paralysis. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20060501
Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Archives of neurology 20060401
Fetal exposure to 3,4-diaminopyridine in a pregnant woman with congenital myasthenia syndrome. The Annals of pharmacotherapy 20060401
Acetylcholinesterase inhibition and orthostatic hypotension. Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20060401
Childhood sexual abuse in relation to neurobiological challenge tests in patients with borderline personality disorder and normal controls. Psychiatry research 20060330
Pyridostigmine reduces QTc interval during recovery from maximal exercise in ischemic heart disease. International journal of cardiology 20060208
[Stopping smoking and constipation]. Presse medicale (Paris, France : 1983) 20060201
Bifunctional compounds eliciting anti-inflammatory and anti-cholinesterase activity as potential treatment of nerve and blister chemical agents poisoning. Journal of applied toxicology : JAT 20060101
[Ocular involvement in MuSK antibody-positive myasthenia gravis]. Klinische Monatsblatter fur Augenheilkunde 20060101
Rapid determination of N,N-diethyl-m-toluamide and permethrin in human plasma by gas chromatography-mass spectrometry and pyridostigmine bromide by high-performance liquid chromatography. Journal of analytical toxicology 20060101
Determination of pyridostigmine bromide and its metabolites in biological samples. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20060101
Circadian rhythms of heart rate and locomotion after treatment with low-dose acetylcholinesterase inhibitors. Journal of applied toxicology : JAT 20060101
Myasthenia gravis disclosed by lithium carbonate. The Journal of neuropsychiatry and clinical neurosciences 20060101
Intestinal pseudo-obstruction as initial presentation of thymoma. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20060101
Acetylcholinesterase inhibition affects cardiovascular structure in mice. Physiological research 20060101
Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman. Chemico-biological interactions 20051215
Bioscavengers for the protection of humans against organophosphate toxicity. Chemico-biological interactions 20051215
Inhibition of guinea pig hemi-diaphragm acetylcholinesterase activity by pyridostigmine bromide and protection against soman toxicity. Chemico-biological interactions 20051215
An ex vivo approach for the evaluation of reversible inhibitors as potential pretreatments against organophosphate toxicity. Chemico-biological interactions 20051215
Pyridostigmine in the treatment of orthostatic hypotension. Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20051201
Nonresponsiveness to anticholinesterase agents in patients with MuSK-antibody-positive MG. Neurology 20051108
Pioglitazone treatment increases spontaneous growth hormone (GH) secretion and stimulated GH levels in polycystic ovary syndrome. The Journal of clinical endocrinology and metabolism 20051001
Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment. The British journal of ophthalmology 20051001
An elderly man with dysphagia and dysarthria. Indian journal of medical sciences 20051001
Coronary vasospasm secondary to hypercholinergic crisis: an iatrogenic cause of acute myocardial infarction in myasthenia gravis. International journal of cardiology 20050901
Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil. Neurology 20050823
Mild interoceptive stressors affect learning and reactivity to contextual cues: toward understanding the development of unexplained illnesses. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050801
Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome. Circulation 20050531
Evaluation of GH reserve in patients with adrenal incidentalomas and biochemical evidence of subclinical autonomous glucocorticoid hypersecretion. Clinical endocrinology 20050501
Vaccination alone or in combination with pyridostigmine promotes and prolongs activation of stress-activated kinases induced by stress in the mouse brain. Journal of neurochemistry 20050501
Off-label administration of drugs to healthy military personnel. Dubious ethics of preventive measures. Journal of medical ethics 20050501
Low-dose cholinesterase inhibitors do not induce delayed effects on cerebral blood flow and metabolism. Pharmacology, biochemistry, and behavior 20050401
Treatment counters low blood pressure upon standing. Mayo Clinic health letter (English ed.) 20050401
Bifunctional compounds eliciting both anti-inflammatory and cholinergic activity as potential drugs for neuroinflammatory impairments. Neuroscience letters 20050307
A T-cell-dependent humoral immune response is preserved during the administration of the nerve agent pre-treatment pyridostigmine bromide in a murine model. International immunopharmacology 20050301
Pharmacologic prophylaxis against nerve agent poisoning. The Israel Medical Association journal : IMAJ 20050301
Peripheral ChE inhibition modulates brain monoamines levels and c-fos oncogene in mice subjected to a stress situation. Neurochemical research 20050301
Myasthenia gravis and a rare complication of chemotherapy. The Medical journal of Australia 20050207
The anti-inflammatory and cholinesterase inhibitor bifunctional compound IBU-PO protects from beta-amyloid neurotoxicity by acting on Wnt signaling components. Neurobiology of disease 20050201
Pyridostigmine for treatment of neurogenic orthostatic hypotension [correction of hypertension]--a follow-up survey study. Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20050201
Do vasoactive neuropeptide autoimmune disorders explain pyridostigmine's association with Gulf War syndrome? Medical hypotheses 20050101
Diagnosis of growth hormone deficiency. Frontiers of hormone research 20050101
[The influence of aminostigmine on the parameters of nonspecific resistance and immune system of the organism upon acute poisoning of benzyl 3-quinuclidylate]. Eksperimental'naia i klinicheskaia farmakologiia 20050101
Old legacies and new paradigms: confusing 'research' and 'treatment' and its consequences in responding to emergent health threats. Journal of health care law & policy 20050101
Statin-associated exacerbation of myasthenia gravis. Neurology 20041214
Cardiac responses of Pacific oyster Crassostrea gigas to agents modulating cholinergic function. Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20041201
New treatment eyed for low blood pressure. Harvard heart letter : from Harvard Medical School 20041201
An in vitro investigation of the effects of the nerve agent pretreatment pyridostigmine bromide on human peripheral blood T-cell function. International immunopharmacology 20041101
Cholinergic stimulation with pyridostigmine protects against exercise induced myocardial ischaemia. Heart (British Cardiac Society) 20041001
Response of myasthenia gravis to rituximab in a patient with non-Hodgkin lymphoma. American journal of hematology 20041001
Facile synthesis and initial PET imaging of novel potential heart acetylcholinesterase imaging agents [11C]pyridostigmine and its analogs. Nuclear medicine and biology 20041001
Minimally invasive gastric bypass in a morbidly obese patient with myasthenia gravis. Obesity surgery 20041001
Early and late reversal of rocuronium with pyridostigmine during sevoflurane anaesthesia in children. Anaesthesia and intensive care 20041001
Pulmonary metastasis 12 years after resection of thymoma with microscopic capsule invasion. Japanese journal of clinical oncology 20041001
The cholinergic system controls ghrelin release and ghrelin-induced growth hormone release in humans. The Journal of clinical endocrinology and metabolism 20040901
Sick veterans pin hopes on Gulf War inquiry. Nature 20040819
Enhanced heart rate variability and baroreflex index after stress and cholinesterase inhibition in mice. American journal of physiology. Heart and circulatory physiology 20040701
Cholinergic stimulation with pyridostigmine increases heart rate variability and baroreflex sensitivity in rats. Autonomic neuroscience : basic & clinical 20040630
Distinct phenotypes of congenital acetylcholine receptor deficiency. Neuromuscular disorders : NMD 20040601
Acetylcholine regulates ghrelin secretion in humans. The Journal of clinical endocrinology and metabolism 20040501
Therapy for nerve agent poisoning. Archives of neurology 20040501
Interactive effects of paraoxon and pyridostigmine on blood-brain barrier integrity and cholinergic toxicity. Toxicological sciences : an official journal of the Society of Toxicology 20040401
[Acute respiratory failure that needs mechanical ventilation: first manifestation of myasthenia gravis]. Anales de medicina interna (Madrid, Spain : 1984) 20040401
Persistent/delayed toxic effects of low-dose sarin and pyridostigmine under physical stress (exercise) in mice. Indian journal of physiology and pharmacology 20040401
Joint pain and hyperalgesia due to pyridostigmine bromide in a patient with myasthenia gravis. Neurology 20040309
Treatment of vincristine-induced bilateral ptosis with pyridoxine and pyridostigmine. Pediatric blood & cancer 20040301
Assessment of GH reserve before and after successful treatment of adult patients with Cushing's syndrome. Clinical endocrinology 20040301
Pemphigus vulgaris acantholysis ameliorated by cholinergic agonists. Archives of dermatology 20040301
Congenital myasthenic syndrome: presentation, electrodiagnosis, and muscle biopsy. Journal of child neurology 20040301
Acute experimental tabun-induced intoxication and its therapy in rats. Central European journal of public health 20040301
Does early treatment of ocular myasthenia gravis with prednisone reduce progression to generalized disease? Journal of the neurological sciences 20040215
The effect of prednisone on the progression from ocular to generalized myasthenia gravis. Journal of the neurological sciences 20040215
Co-exposure to pyridostigmine bromide, DEET, and/or permethrin causes sensorimotor deficit and alterations in brain acetylcholinesterase activity. Pharmacology, biochemistry, and behavior 20040201
Lambert-Eaton myasthenic syndrome. Revue neurologique 20040201
Effects of fosphenytoin on nerve agent-induced status epilepticus. Drug and chemical toxicology 20040201
Pyridostigmine bromide (PYR) alters immune function in B6C3F1 mice. Immunopharmacology and immunotoxicology 20040201
Stress and combined exposure to low doses of pyridostigmine bromide, DEET, and permethrin produce neurochemical and neuropathological alterations in cerebral cortex, hippocampus, and cerebellum. Journal of toxicology and environmental health. Part A 20040123
Neurobiological correlates of diagnosis and underlying traits in patients with borderline personality disorder compared with normal controls. Psychiatry research 20040101
Low-level exposure of guinea pigs and marmosets to sarin vapour in air: lowest-observable-adverse-effect level (LOAEL) for miosis. Journal of applied toxicology : JAT 20040101
New approaches to the treatment of pemphigus. The journal of investigative dermatology. Symposium proceedings 20040101
Acute neuromuscular failure related to long-term botulinum toxin therapy. European neurology 20040101
Myasthenia gravis: an unusual cause of diplopia in polymyalgia rheumatica. Clinical and experimental rheumatology 20040101
Low levels of sarin affect the EEG in marmoset monkeys: a pilot study. Journal of applied toxicology : JAT 20040101
Pyridostigmine in postpolio syndrome: no decline in fatigue and limited functional improvement. Journal of neurology, neurosurgery, and psychiatry 20031201
Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of pyridostigmine bromide from guinea pig plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20031105
Effects of daily stress or repeated paraoxon exposures on subacute pyridostigmine toxicity in rats. Archives of toxicology 20031001
Acetylcholinesterase inhibition in the treatment of hypotension. Journal of neurology, neurosurgery, and psychiatry 20030901
Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. Journal of neurology, neurosurgery, and psychiatry 20030901
Heart rate variability in chronic heart failure: target for therapy? American heart journal 20030901
Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure. American heart journal 20030901
Unilateral headache due to myasthenia gravis. Cephalalgia : an international journal of headache 20030901
Combined forced running stress and subclinical paraoxon exposure have little effect on pyridostigmine-induced acute toxicity in rats. Toxicology 20030828
Cardiac function during mental stress: cholinergic modulation with pyridostigmine in healthy subjects. Clinical science (London, England : 1979) 20030801
Acetylcholinesterase inhibition with pyridostigmine improves heart rate recovery after maximal exercise in patients with chronic heart failure. Heart (British Cardiac Society) 20030801
Childhood ocular myasthenia gravis. Ophthalmology 20030701
Comparative efficacy of diazepam and avizafone against sarin-induced neuropathology and respiratory failure in guinea pigs: influence of atropine dose. Toxicology 20030630
Gulf War syndrome revisited. EMBO reports 20030601
Controlled intermittent asystole cardiac therapy induced by pharmacologically potentiated vagus nerve stimulation in normal and hibernating myocardium. The Annals of thoracic surgery 20030601
Myasthenia gravis and masticatory muscle myositis in a dog. The Canadian veterinary journal = La revue veterinaire canadienne 20030601
Parkinson's disease associated with myasthenia gravis. A report of 4 cases. Journal of neurology 20030601
Prolonged treatment with glycerophosphocholine, an acetylcholine precursor, does not disclose the potentiating effect of cholinesterase inhibitors on GHRH-induced somatotroph secretion in anorexia nervosa. Journal of endocrinological investigation 20030601
Stress interacts with peripheral cholinesterase inhibitors to cause central nervous system effects. Life sciences 20030523
Take your pyridostigmine: that's an (ethical?) order! The Lancet. Neurology 20030501
Control of nerve agent-induced seizures is critical for neuroprotection and survival. Toxicology and applied pharmacology 20030415
Re-assessment of growth hormone secretion in young adult patients with childhood-onset growth hormone deficiency. Clinical endocrinology 20030401
Changes in respiratory condition after thymectomy for patients with myasthenia gravis. Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 20030401
Neuroprotective efficacy of pharmacological pretreatment and antidotal treatment in tabun-poisoned rats. Toxicology 20030314
Clinical trials. New rule triggers debate over best way to test drugs. Science (New York, N.Y.) 20030314
Thymectomy in ocular myasthenia gravis. The Journal of thoracic and cardiovascular surgery 20030301
Effect of chronic pyridostigmine bromide treatment on cardiovascular and behavioral parameters in mice. Pharmacology, biochemistry, and behavior 20030301
Pyridostigmine bromide modulates topical irritant-induced cytokine release from human epidermal keratinocytes and isolated perfused porcine skin. Toxicology 20030201
[Ogilvie's syndrome: a rare cause of the acute abdomen]. Zeitschrift fur Gastroenterologie 20030201
Pyridostigmine enhances glutamatergic transmission in hippocampal CA1 neurons. Experimental neurology 20030201
Impact of growth hormone on central nervous activity, vigilance, and tiredness after short-term therapy in growth hormone-deficient adults. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20030201
Percutaneous absorption of topical N,N-diethyl-m-toluamide (DEET): effects of exposure variables and coadministered toxicants. Journal of toxicology and environmental health. Part A 20030124
Testicular germ-cell apoptosis in stressed rats following combined exposure to pyridostigmine bromide, N,N-diethyl m-toluamide (DEET), and permethrin. Journal of toxicology and environmental health. Part A 20030110
Effects of long-term estrogen replacement therapy on growth hormone response to pyridostigmine in healthy postmenopausal women. Psychoneuroendocrinology 20030101
Low concentrations of pyridostigmine prevent soman-induced inhibition of GABAergic transmission in the central nervous system: involvement of muscarinic receptors. The Journal of pharmacology and experimental therapeutics 20030101
Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans. Clinical endocrinology 20030101
Pyridostigmine for fibromyalgia: comment on the article by Paiva and a historical vignette. Arthritis and rheumatism 20030101
Thymectomy in nonthymoma early-onset myasthenia gravis in correlation with disease severity and muscle autoantibodies. European neurology 20030101
Double trouble. Survey of ophthalmology 20030101
Heightening awareness of myasthenia gravis, its presentation, symptoms and new treatments that are now available. Journal of the Irish Dental Association 20030101
A comparison of the neuroprotective efficacy of pharmacological pretreatment and antidotal treatment in soman-poisoned rats. Acta medica (Hradec Kralove) 20030101
Effect of methoxime combined with anticholinergic, anticonvulsant or anti-HCN drugs in tabun-poisoned mice. Acta medica (Hradec Kralove) 20030101
The effect of use of pyridostigmine and requirement of vecuronium in patients with myasthenia gravis. Journal of postgraduate medicine 20030101
A typical case of Myasthenia Gravis. Kathmandu University medical journal (KUMJ) 20030101
Intravenous immunoglobulin monotherapy in long-term treatment of myasthenia gravis. Clinical neurology and neurosurgery 20021201
Residual paralysis induced by either vecuronium or rocuronium after reversal with pyridostigmine. Anesthesia and analgesia 20021201
Autosomal recessive limb girdle myasthenia in two sisters. Neurology India 20021201
Protein binding of isofluorophate in vivo after coexposure to multiple chemicals. Environmental health perspectives 20021201
Myasthenia mimicking vertebrobasilar stroke. Journal of neurology 20021101
In myasthenia gravis, clinical and immunological improvement post-thymectomy segregate with results of in vitro antibody secretion by immunocytes. Journal of the neurological sciences 20021015
Pharmacokinetic/pharmacodynamic modeling of rocuronium in myasthenic patients is improved by taking into account the number of unbound acetylcholine receptors. Anesthesia and analgesia 20020901
Complete inhibition of hypothalamic somatostatin activity is only partially responsible for the growth hormone response to strenuous exercise. Metabolism: clinical and experimental 20020901
Acute and repeated restraint stress have little effect on pyridostigmine toxicity or brain regional cholinesterase inhibition in rats. Toxicological sciences : an official journal of the Society of Toxicology 20020901
Physostigmine and hyoscine improves protection against the lethal and incapacitating effects of nerve agent poisoning in the guinea-pig. Neurotoxicology 20020901
Preparation and in vitro evaluation of pyridostigmine bromide microparticles. International journal of pharmaceutics 20020821
A comparison of the efficacy of pyridostigmine alone and the combination of pyridostigmine with anticholinergic drugs as pharmacological pretreatment of tabun-poisoned rats and mice. Toxicology 20020815
Myasthenia gravis in pregnancy: report on 69 cases. European journal of obstetrics, gynecology, and reproductive biology 20020805
Locomotor and sensorimotor performance deficit in rats following exposure to pyridostigmine bromide, DEET, and permethrin. Alone and in combination. Toxicological sciences : an official journal of the Society of Toxicology 20020801
Subchronic administration of pyridostigmine or huperzine to primates: compared efficacy against soman toxicity. Drug and chemical toxicology 20020801
Altered hypothalamic cholinergic responses in patients with nonulcer dyspepsia: a study of pyridostigmine-stimulated growth hormone release. The American journal of gastroenterology 20020801
Neither forced running nor forced swimming affect acute pyridostigmine toxicity or brain-regional cholinesterase inhibition in rats. Toxicology 20020701
Sensitivity to vecuronium in seropositive and seronegative patients with myasthenia gravis. Anesthesia and analgesia 20020701
Physiological and performance effects of pyridostigmine bromide in healthy volunteers: a dose-response study. Psychopharmacology 20020701
Use of intravenous pulsed cyclophosphamide in severe, generalized myasthenia gravis. Muscle & nerve 20020701
[Ptosis and mastication disorders revealing concurrent myasthenia gravis and chronic polyradiculoneuritis]. Revue neurologique 20020701
Pyridostigmine bromide modulates the dermal disposition of [14C]permethrin. Toxicology and applied pharmacology 20020615
[Growth disorders in Down's syndrome: growth hormone treatment]. Minerva endocrinologica 20020601
Cholinergic stimulation with pyridostigmine reduces the QTc interval in coronary artery disease. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20020601
Pyridostigmine bromide and the long-term subjective health status of a sample of over 700 male Reserve Component Gulf War era veterans. Psychological reports 20020601
Actions of pyridostigmine and organophosphate agents on chick cells, mice, and chickens. Drug and chemical toxicology 20020501
Binding of pyridostigmine bromide, N,N-diethyl-m-toluamide and permethrin, alone and in combinations, to human serum albumin. Archives of toxicology 20020501
Impaired growth hormone secretion in fibromyalgia patients: evidence for augmented hypothalamic somatostatin tone. Arthritis and rheumatism 20020501
In vitro human metabolism and interactions of repellent N,N-diethyl-m-toluamide. Drug metabolism and disposition: the biological fate of chemicals 20020301
Sensorimotor deficit and cholinergic changes following coexposure with pyridostigmine bromide and sarin in rats. Toxicological sciences : an official journal of the Society of Toxicology 20020301
Indirect evidence for decreased hypothalamic somatostatinergic tone in anorexia nervosa. Clinical endocrinology 20020301
Pyridophens: binary pyridostigmine-aprophen prodrugs with differential inhibition of acetylcholinesterase, butyrylcholinesterase, and muscarinic receptors. Journal of medicinal chemistry 20020214
Peripheral cholinergic pathway modulates hyperthermia induced by stress in rats exposed to open-field stress. Journal of applied physiology (Bethesda, Md. : 1985) 20020201
Presentation of myasthenia gravis mimicking blepharospasm. Neurology 20020108
Prevention and treatment of injury from chemical warfare agents. The Medical letter on drugs and therapeutics 20020107
The use of the pyridostigmine growth hormone-releasing hormone stimulation test to detect growth hormone deficiency in patients with pituitary adenomas. Metabolism: clinical and experimental 20020101
Ocular myasthenia presenting as progressive external ophthalmoplegia. Journal of pediatric ophthalmology and strabismus 20020101
Major review: the clinical spectrum of pediatric myasthenia gravis: blepharoptosis, ophthalmoplegia and strabismus. A report of 14 cases. Binocular vision & strabismus quarterly 20020101
Cardiorespiratory effects following acute exposure to pyridostigmine bromide and/or N,N-diethyl-m-toluamide (DEET) in rats. International journal of toxicology 20020101
[Respiratory arrests caused by congenital myasthenia gravis syndrome]. Duodecim; laaketieteellinen aikakauskirja 20020101
Determination of physostigmine and pyridostigmine in pharmaceutical formulations by capillary electrophoresis. Journal of capillary electrophoresis and microchip technology 20020101
A validated HPLC method for the determination of pyridostigmine bromide, acetaminophen, acetylsalicylic acid and caffeine in rat plasma and urine. Journal of pharmaceutical and biomedical analysis 20011201
Effects of contralateral white noise stimulation on distortion product otoacoustic emissions in myasthenic patients. Hearing research 20011201
Side effects of low-dose pyridostigmine bromide are not related to cholinesterase inhibition. Aviation, space, and environmental medicine 20011201
The effect of continuous pyridostigmine administration on functional (A12) acetylcholinesterase activity in guinea-pig muscles. Neurotoxicology 20011201
Insulin-like growth factor-I restores the reduced somatostatinergic tone controlling growth hormone secretion in cirrhotic rats. Liver 20011201
Beneficial effects of TCP on soman intoxication in guinea pigs: seizures, brain damage and learning behaviour. Journal of applied toxicology : JAT 20011201
Reactive oxygen species mediate pyridostigmine-induced neuronal apoptosis: involvement of muscarinic and NMDA receptors. Toxicology and applied pharmacology 20011115
Fetal antigen 1 in healthy adults and patients with pituitary disease: relation to physiological, pathological, and pharmacological GH levels. The Journal of clinical endocrinology and metabolism 20011101
Determination of depleted uranium, pyridostigmine bromide and its metabolite in plasma and urine following combined administration in rats. Journal of pharmaceutical and biomedical analysis 20010901
The use of carbamates, atropine, and 2-pyridine aldoxime methoiodide in the protection of Artemia salina against poisoning by carbophenothion. Environmental toxicology and chemistry 20010901
Electroplegia: an alternative to blood cardioplegia for arresting the heart during conventional (on-pump) cardiac operation. The Annals of thoracic surgery 20010901
Myasthenia gravis in children: analysis of 18 patients. Arquivos de neuro-psiquiatria 20010901
Combined exposure to sarin and pyridostigmine bromide increased levels of rat urinary 3-nitrotyrosine and 8-hydroxy-2'-deoxyguanosine, biomarkers of oxidative stress. Toxicology letters 20010806
High-performance liquid chromatographic determination of pyridostigmine bromide, nicotine, and their metabolites in rat plasma and urine. Journal of chromatographic science 20010701
Pyridostigmine-induced microcephaly. Neurology 20010612
Pyridostigmine-induced microcephaly. Neurology 20010612
Evaluation of immunotoxicity induced by single or concurrent exposure to N,N-diethyl-m-toluamide (DEET), pyridostigmine bromide (PYR), and JP-8 jet fuel. Toxicology and industrial health 20010601
Myasthenia gravis with autoimmune autonomic neuropathy. Autonomic neuroscience : basic & clinical 20010514
Subchronic administration of various pretreatments of nerve agent poisoning. I. Protection of blood and central cholinesterases, innocuousness towards blood-brain barrier permeability. Drug and chemical toxicology 20010501
Subchronic administration of various pretreatments of nerve agent poisoning. II. Compared efficacy against soman toxicity. Drug and chemical toxicology 20010501
Impairment of GH responsiveness to GH-releasing hexapeptide (GHRP-6) in Prader-Willi syndrome. Journal of endocrinological investigation 20010501
Induction of urinary excretion of 3-nitrotyrosine, a marker of oxidative stress, following administration of pyridostigmine bromide, DEET (N,N-diethyl-m-toluamide) and permethrin, alone and in combination in rats. Toxicology letters 20010430
Chromatographic method for the determination of diazepam, pyridostigmine bromide, and their metabolites in rat plasma and urine. Journal of chromatography. B, Biomedical sciences and applications 20010425
Development of a high-performance liquid chromatographic method for the quantification of chlorpyrifos, pyridostigmine bromide, N,N-diethyl-m-toluamide and their metabolites in rat plasma and urine. Journal of chromatography. B, Biomedical sciences and applications 20010425
Locomotor and sensorimotor performance deficit in rats following exposure to pyridostigmine bromide, DEET, and permethrin, alone and in combination. Toxicological sciences : an official journal of the Society of Toxicology 20010401
Analysis of thymectomy for myasthenia gravis in older patients: a 20-year single institution experience. Journal of the American College of Surgeons 20010401
Exercise stress testing in healthy subjects during cholinergic stimulation after a single dose of pyridostigmine. Arquivos brasileiros de cardiologia 20010401
Familial autoimmune myasthenia gravis. Singapore medical journal 20010401
Cocaine abuse, generalized myasthenia, complete external ophthalmoplegia, and pseudotonic pupil. Strabismus 20010301
Central nervous system effects from a peripherally acting cholinesterase inhibiting agent: interaction with stress or genetics. Annals of the New York Academy of Sciences 20010301
Laryngeal myasthenia gravis: report of 40 cases. Journal of voice : official journal of the Voice Foundation 20010301
Pyridostigmine bromide and the long-term subjective health status of a sample of female reserve component Gulf War veterans: a brief report. Psychological reports 20010201
Perioperative management of a patient with congenital myasthenia gravis for elective caesarean section. Singapore medical journal 20010201
Many Gulf War illnesses may be autoimmune disorders caused by the chemical and biological stressors pyridostigmine bromide, and adrenaline. Medical hypotheses 20010201
Enhancement of heart rate variability by cholinergic stimulation with pyridostigmine in healthy subjects. Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20010201
Viral neuroinvasion as a marker for BBB integrity following exposure to cholinesterase inhibitors. Life sciences 20010119
A dose-response study of anticholinesterase drugs on contractile and phosphatidylinositol responses of rat trachea. Anesthesia and analgesia 20010101
Biological consequences of multiple vaccine and pyridostigmine pretreatment in the guinea pig. Journal of applied toxicology : JAT 20010101
Bulbar presentations of myasthenia gravis in the elderly patient. The Journal of laryngology and otology 20010101
The effects of pyridostigmine bromide on progressive ratio performance in male and female rats. Pharmacology, biochemistry, and behavior 20010101
The role of cholinergic transmission in outer hair cell functioning evaluated by distortion product otoacoustic emissions in myasthenic patients. Acta oto-laryngologica 20010101
The use of intravenous immunoglobulin as maintenance therapy in myasthenia gravis. Clinical neuropharmacology 20010101
The effects of pyridostigmine bromide, permethrin, and DEET alone, or in combination, on fixed-ratio and fixed-interval behavior in male and female rats. Pharmacology, biochemistry, and behavior 20010101
Interaction of pyridostigmine and physical stress on antioxidant defense system in skeletal muscle of mice. Journal of applied toxicology : JAT 20010101
[Myasthenia gravis associated with HIV infection]. Ryoikibetsu shokogun shirizu 20010101
The combined effects of pyridostigmine and chronic stress on brain cortical and blood acetylcholinesterase, corticosterone, prolactin and alternation performance in rats. Pharmacology, biochemistry, and behavior 20010101
Prognostic factors of thymectomy in patients with myasthenia gravis: a cohort of 132 patients. European neurology 20010101
Neurotoxicology of the brain barrier system: new implications. Journal of toxicology. Clinical toxicology 20010101
Ritonavir-associated myasthenia gravis. Muscle & nerve 19980501
[Myasthenic crisis caused by azathioprine-induced fever]. Der Nervenarzt 19970401
Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli. The Journal of clinical endocrinology and metabolism 19960301
Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression. The Journal of clinical endocrinology and metabolism 19960301
Myasthenia gravis and levonorgestrel implant. Lancet (London, England) 19951209
Myasthenia gravis following iron chelation therapy with intravenous desferrioxamine. European journal of haematology 19950801
D-penicillamine induced myasthenia gravis in rheumatoid arthritis: an unpredictable common occurrence? Clinical rheumatology 19941201
[D-penicillamine-induced myasthenia gravis]. Schweizerische medizinische Wochenschrift 19940521
Influence of endogenous cholinergic tone and alpha-adrenergic pathways on growth hormone responses to His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 in the dog. The Journal of endocrinology 19930801
Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity. The Journal of clinical endocrinology and metabolism 19930401
[A comparison of the two anticholinergic agents atropine and glycopyrrolate during antagonism of a muscle relaxation with pyridostigmine]. Anaesthesiologie und Reanimation 19930101
Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man. The Journal of clinical endocrinology and metabolism 19930101
Myasthenia gravis presenting as weakness after magnesium administration. Muscle & nerve 19900801
Long term treatment of myasthenia gravis with azathioprine. Postgraduate medical journal 19900201
Prolonged paralysis associated with long-term pancuronium use. Pharmacotherapy 19890101
Parkinsonism induced by pyridostigmine. Acta neurologica Scandinavica 19880901
[Acetylcholine receptor antibody in D-penicillamine therapy]. Zeitschrift fur Rheumatologie 19860101
[Hemodynamic effects in antagonism of neuromuscular blockage: atropine-pyridostigmine versus ipratropium bromide-pyridostigmine]. Der Anaesthesist 19841001
Penicillamine induced myasthenia reactivated by gold. British medical journal (Clinical research ed.) 19840121
[Myasthenic syndrome--complication of D-penicillamine therapy]. Zeitschrift fur arztliche Fortbildung 19840101
D-penicillamine-induced myasthenia gravis in primary biliary cirrhosis. Gastroenterology 19840101
[Myasthenia syndrome during chloroquine treatment (author's transl)]. Deutsche medizinische Wochenschrift (1946) 19811225
Myasthenia gravis and penicillamine therapy of rheumatoid arthritis. JAMA 19801017
Timolol and myasthenia gravis. JAMA 19791012
[A myasthenic reaction provoked by lithium carbonate treatment]. Ugeskrift for laeger 19780925
[Myasthenia syndrome after peroral treatment with penicillamine]. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 19780101
D-Penicillamine-induced myasthenia gravis in rheumatoid arthritis. Annals of internal medicine 19771101
Cardiac arrest and arrhythmias due to self-poisoning with imipramine. Anaesthesia 19690101

Related Products

© 2019 Angene International Limited. All rights Reserved.